Keywords: ipsen, filed, bsa, dysport, fda, france, says

Ipsen filed BSA for Dysport with FDA

Article | 10 December 2007

Print This

France's Ipsen says that it has submitted a Biologics License Application for Dysport for Injection, a botulinum neurotoxin type A ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in